MedPath
HSA Approval

MIDAZOLAM-HAMELN 5 MG/ML INJECTION

SIN12553P

MIDAZOLAM-HAMELN 5 MG/ML INJECTION

MIDAZOLAM-HAMELN 5 MG/ML INJECTION

June 16, 2004

ZYFAS PHARMA PTE LTD

ZYFAS PHARMA PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantZYFAS PHARMA PTE LTD
Licence HolderZYFAS PHARMA PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

N05CD08

midazolam

Manufacturer Information

ZYFAS PHARMA PTE. LTD.

Siegfried Hameln GmbH

Active Ingredients

MIDAZOLAM HYDROCHLORIDE 5.56 mg/ml EQV MIDAZOLAM

5 mg/ml

Midazolam

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.